Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study

BACKGROUND: Despite the latest World Health Organization guidelines advocating daily therapy in HIV-TB co-infected individuals, there are few recent studies comparing outcomes of thrice-weekly anti-tuberculosis treatment in HIV-positive and HIV-negative patients with TB. The present study sets out t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vashishtha, Richa, Mohan, Krishna, Singh, Bhagteshwar, Devarapu, Satish K, Sreenivas, Vishnubhatla, Ranjan, Sanjay, Gupta, Deepak, Sinha, Sanjeev, Sharma, Surendra K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852441/
https://www.ncbi.nlm.nih.gov/pubmed/24099345
http://dx.doi.org/10.1186/1471-2334-13-468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852441/
https://www.ncbi.nlm.nih.gov/pubmed/24099345
http://dx.doi.org/10.1186/1471-2334-13-468

Ejemplares similares